Optimising maintenance therapy after transplantation: sorafenib's role in patients with FLT3-ITD acute myeloid leukaemia.

Article

The Lancet. Haematology - 1 Aug 2023

Yilmaz Musa, Daver Naval

Abstract excerpt

No abstract is available from the source.

Community interpretation

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.